The signed memorandum was a logical continuation of the visit by scientists from the Institute of Personalized Oncology of the First Moscow State Medical University to China in the fall of 2025. At that time, the researchers studied the experience of their Chinese colleagues in the production of anticancer vaccines based on patients' T-lymphocytes and agreed to conduct clinical trials of an innovative Chinese targeted drug for the treatment of nasopharyngeal and esophageal cancer. This drug is already being used to treat patients in China, and now it has begun to be used at the Clinical Center for Health Sciences at Sechenov University. In the future, by combining this data, scientists will be able to compare the effectiveness of therapy and develop optimal treatment protocols for different population groups.
“We have seen the first positive results in study participants with advanced nasopharyngeal adenocarcinoma,” said Marina Sekacheva, director of the Institute of Personalized Oncology. “This is a very rare disease in the Russian population, but quite common in China. Patients who received the innovative targeted drug felt better after the first course of therapy. We hope that further treatment will help improve their quality of life and reduce the tumor size to allow for radical surgery.”
The memorandum, signed during a return visit by Chinese colleagues to Sechenov University in February 2026, expands the areas of cooperation between scientists from both countries. The parties will establish a mirror laboratory at First Moscow State Medical University for joint research in the field of CAR-T and TIL therapies and mRNA technologies. The partners' immediate plans include the development of targeted cell-based antitumor therapy for the treatment of sarcoma and lung cancer. The first joint scientific article on the molecular mechanism of sarcoma development and immunotherapeutic treatment of this cancer is already being prepared for publication in a leading international oncology journal. In addition, the parties will launch joint educational programs for students and doctors in oncology, surgery, hematology, and other fields. The Chinese project leader, Professor Heiyan Hu, chief physician of the oncology department at Shanghai Sixth Municipal Hospital, will become a visiting professor at First Moscow State Medical University in 2026 and will lecture and conduct research at the university.
Moscow Polytechnic University has announced the launch of a new large-scale project, “Around the World Together,” aimed at strengthening intercultural ties. The initiative, developed by the university’s International Office, will serve as a platform for learning about the traditions and history of countries represented by both international students and Russian students.
Kazan Federal University, together with scientists from Sharof Rashidov Samarkand State University, Samarkand State Institute of Foreign Languages, and Shakhrisabz State Pedagogical Institute, organized an international scientific conference entitled Modern Pedagogical Education in International, National, and Regional Dimensions. Following the conference, a collection of scientific papers was published by a foreign publishing house.
The project, organized by the International Youth Center of RUDN in conjunction with the Russian Ministry of Education and Science, will help future graduates deepen their knowledge in the fields of business, international relations, and grant activities, as well as open up new career prospects in Russia and abroad.
The Center had previously been operating successfully at the Institute and providing comprehensive support to foreign students, but it has only now acquired its own space.
The Russian-Arabic Language and Culture Club has opened at the SPbPU Institute of Humanities. The new student initiative is aimed at developing intercultural dialogue, strengthening humanitarian ties and expanding international cooperation of the university.
